IP Library Granted Patent US 9,301,973
Granted Patent B2
US 9,301,973 · App. 13/881,507 · Granted Apr 5, 2016

Methods and compositions suitable for promoting healthy skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,301,973
App. No.
13/881,507
Granted
Apr 5, 2016
Kind
B2
Abstract

The invention provides methods, compositions, and dietary formulations useful for preventing or treating dermatitis, promoting healthy skin, and retarding skin aging. The methods comprise administering to an animal a therapeutically effective amount of a combination of at least two of one or more antioxidants; one or more anti-glycation agents; one or more body fat reducing agents; one or more insulin sensitivity enhancing agents; and one or more anti-inflammatory agents.

Claims (11)

1. A method for treating dermatitis in an animal comprising administering to the animal having dermatitis a therapeutically effective amount of a combination of:

one or more antioxidants selected from the group consisting of vitamin C, polyphenols, proanthocyanidins, anthocyanins, bioflavonoids, selenium, alpha-lipoic acid, glutathione, catechin, epicatechin, epigallocatechin, epigallocatechin gallate, epicatechin gallate, cysteine, vitamin E, gamma tocopherol, alpha-carotene, beta-carotene, lutein, zeaxanthin, retinal, astaxanthin, cryptoxanthin, lycopene and resveratrol, wherein the antioxidants are administered to the animal in amounts of from about 0.001 to about 1000 mg/kg/day;

one or more anti-glycation agents selected from the group consisting of carnosine, benfotiamine, pyridoxamine, alpha-lipoic acid, phenacyldimethylthiazolium chloride, taurine, aminoguanidine, resveratrol, and aspirin, wherein the anti-glycation agents are administered to the animal in amounts of from about 0.01 to about 1000 mg/kg/day;

one or more body fat reducing agents selected from the group consisting of conjugated linoleic acid (CLA), carnitine, acetyl-carnitine, pyruvate, polyunsaturated fatty acids, medium chain fatty acids, medium chain triglycerides, and soy isoflavones, wherein the body fat reducing agents are administered to the animal in amounts of from about 0.001 to about 1000 mg/kg/day; and

one or more insulin sensitivity enhancing agents selected from the group consisting of chromium, chromium picolinate, cinnamon, cinnamon extract, polyphenols from cinnamon and witch hazel, coffee berry extract, chlorogenic acid, caffeic acid, a source of zinc, and grape seed extract, wherein the insulin sensitivity enhancing agents are administered to the animal in amounts of from about 0.001 to about 1000 mg/kg/day,

wherein the combination excludes anti-inflammatory agents of omega-3 fatty acids and curcumin.

2. The method of claim 1 , wherein the one or more antioxidants includes vitamin E, vitamin C, alpha-carotene, beta-carotene, lutein, zeaxanthin, cryptoxanthin, selenium, and lycopene; wherein the one or more insulin sensitivity enhancing agents include chromium, grape seed extract, and zinc; wherein the one or more body fat reducing agents include CLA, carnitine, and acetyl-carnitine; and the one or more anti-glycation agents include carnosine.

3. The method of claim 1 , wherein the antioxidants are administered to the animal in amounts of from about 0.001 to about 10 grams per day.

4. The method of claim 1 , wherein the anti-glycation agents are administered to the animal in amounts of from about 0.01 to about 10 grams per day.

5. The method of claim 1 , wherein the body fat reducing agents are administered to the animal in amounts of from about 0.01 to about 10 grams per day.

6. The method of claim 1 , wherein the insulin sensitivity enhancing agents are administered to the animal in amounts of from about 0.01 to about 10 grams per day.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2016
From: PAN, YUANLONG; HANNAH, STEVEN SCOTT; MIDDLETON, RONDO P
To: NESTEC SA
Reel/Frame 037826/0974 →